News

Industry 5.0 Award 2023- open for submission

Published on | 2 years ago

Programmes Health Culture and society Security Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment EIC EIT Health Food Energy Transport Climate/Environment Societies Security EIC Pilot

What:
It is a non-monetary recognition for EU-funded projects. The winning project, as well as the two other finalists will receive communication support and visibility on the European Commission’s channels, including social media publicity and an article in the Horizon Magazine.

For whom:
Eligible projects must have obtained funding (on-going or completed) or seals of excellence from Horizon 2020, Horizon Europe or EIT. Projects involving deep-tech start-ups are particularly encouraged to participate. The projects should present inspiring and applicable solutions addressing sustainaibility, human-centricity and resilience. 

From whom:
The award is a collaboration of European Factories of the Future Research Association (EFFRA), the industrial platform MANUFUTURE, the European Innovation Council and SMEs Executive Agency (EISMEA) and EIT Manufacturing.

Deadline for submission: 1st of September 2023

More information:
The application form, rules of the contest, guidelines and the award winner of 2022, can be found on this page.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1705 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.